SCHEMBL687065

SCHEMBL687065

CCCCNCCC[SiH2]OC

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.46
ALDH1A1 P00352 1/20 0.46
CYP2C19 P33261 2/20 0.35
KMT2A Q03164 2/20 0.35
MEN1 O00255 1/20 0.35
GLA P06280 1/20 0.35
ADH1B P00325 1/20 0.34
ADH1C P00326 1/20 0.34
ADH1A P07327 1/20 0.34
ADH7 P40394 1/20 0.34
HRH4 Q9H3N8 2/20 0.33
HRH3 Q9Y5N1 2/20 0.33
CYP1A2 P05177 1/20 0.33
S1PR2 O95136 5/20 0.31
S1PR4 O95977 5/20 0.31
S1PR1 P21453 5/20 0.31
S1PR3 Q99500 5/20 0.31
S1PR5 Q9H228 1/20 0.31
SIGMAR1 Q99720 1/20 0.31
CA12 O43570 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28647993 0.91 TSHR (0.40) TSHRALDH1A1CYP2C19KMT2AMEN1
SCHEMBL8984823 0.91 CYP2C19 (0.35) TSHRALDH1A1CYP2C19KMT2AMEN1
Bromide SCHEMBL28263939 0.90 TSHR (0.52) TSHRALDH1A1CYP2C19ADH1BADH1C
Iodide SCHEMBL28868954 0.90 TSHR (0.52) TSHRALDH1A1CYP2C19ADH1BADH1C
SCHEMBL28735575 0.83 TSHR (0.39) TSHRALDH1A1CYP2C19KMT2AMEN1
SCHEMBL19669 0.82 CA12 (0.48) TSHRALDH1A1CYP2C19KMT2AMEN1
SCHEMBL27591294 0.80 CA12 (0.46) TSHRALDH1A1CYP2C19KMT2AMEN1
SCHEMBL8206827 0.80 CA12 (0.48) TSHRALDH1A1CYP2C19KMT2AMEN1
SCHEMBL18329453 0.80 TSHR (0.44) TSHRALDH1A1CYP2C19KMT2AMEN1
SCHEMBL704639 0.80

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180030071-A1 HYDRIDOSILAPYRROLES, HYDRIDOSILAAZAPYRROLES, THIASILACYCLOPENTANES, METHOD FOR PREPARATION THEREOF, AND REACTION PRODUCTS THEREFROM GELEST, INC. 2018-02-01 US disclosed
EP-1829925-B1 RUBBER COMPOSITION, METHOD FOR PRODUCING SAME AND TIRE BRIDGESTONE CORP (JP) 2012-02-29 EP disclosed
US-20090124742-A1 Rubber Composition, Method for Producing Same and Tire BRIDGESTONE CORPORATION (JP) 2009-05-14 US disclosed
EP-1829925-A1 RUBBER COMPOSITION, METHOD FOR PRODUCING SAME AND TIRE Bridgestone Corporation (JP) 2007-09-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180030071-A1 HYDRIDOSILAPYRROLES, HYDRIDOSILAAZAPYRROLES, THIASILACYCLOPENTANES, METHOD FOR PREPARATION THEREOF, AND REACTION PRODUCTS THEREFROM HAAO, TST, TH TSHR 352/4885ALDH1A1 1281/4885CYP2C19 63/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.